You just read:

Abide Therapeutics Announces First Subject Dosed In PET Occupancy Study with [18F]ABX-1488, A Proprietary Human Monoacylglycerol Lipase (MGLL)-Specific PET Ligand

News provided by

Abide Therapeutics

May 10, 2016, 08:00 ET